Real-time enrollment status for this acute myeloid leukemia, relapsed, adult clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 11:00 AM UTC
| NCT Number | NCT06802315 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia, Relapsed, Adult |
| Phase | PHASE2 |
| Target Enrollment | 38 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Illinois at Chicago |
| Last Updated on CT.gov | June 26, 2026 (Jun 26, 2026) |
As of August 29, 2026: Clinical trial NCT06802315 is currently recruiting participants. This phase2 study for acute myeloid leukemia, relapsed, adult is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Illinois at Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06802315 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06802315 was last updated Jun 26, 2026 (June 26, 2026). HelloStudys verifies this status automatically.